Acquired hemophilia A (AHA) is a rare bleeding disorder with an incidence of approximately 1.5 cases/million/year,[1] which is characterized by autoantibodies directed against circulating coagulation factor (F) VIII. Here, F8 is linked to autoimmune hemolytic anemia.